Search

Wei Duo Huang

from San Francisco, CA
Age ~61
Get Report
Also known as:
Wei D Huang, Weiduo D Huang, Wei Duo Chen
Related to:
Jialiang Chen, 32Zhiwen ChenHui Chen, 58
Connected to:
Ada Huang, 36Aiqing Huang, 51Aizi Huang, 56Amy H Huang, 44Angelina A Huang, 52Ashley Huang, 52Baoyi Huang, 32Carber C Huang, 57Caroline Huang, 46Cathleen Huang, 31

Wei Huang Phones & Addresses

  • San Francisco, CA

Professional Records

Lawyers & Attorneys

Wei Huang Photo 1

Wei Huang - Lawyer

View page
Specialties:
Intellectual Property Litigation
Intellectual Property Infringement
Intellectual Property Rights
Trademarks
Trademark Infringement
Trademark Prosecution
Trademark Protection
Trademark Registration
Trademark Licensing
Business Litigation
Contracts
Business Law
Intellectual Property
International Law
Litigation
Patent Application
Corporate & Incorporation
Patent Application
ISLN:
157121232
Admitted:
2010
University:
Taipei Medical University, B.S., 2006
Law School:
The University of Texas School of Law, Austin, Texas, J.D., 2010; The University of Texas School of Law, Austin, Texas, J.D., 2010

Medicine Doctors

Wei Huang Photo 2

Dr. Wei S Huang, Alameda CA - DDS (Doctor of Dental Surgery)

View page
Specialties:
Dentistry
Address:
2245 Santa Clara Ave Suite 2, Alameda, CA 94501
(510) 522-1198 (Phone)
Languages:
English
Wei Huang Photo 3

Wei Huang

View page
Specialties:
Anatomic Pathology & Clinical Pathology
Work:
UW Health ClinicsUW Hospital Pathology Clinic
600 Highland Ave, Madison, WI 53792
(608) 263-8437 (phone), (608) 262-6337 (fax)
Education:
Medical School
The Third Military Med Univ, Chongqing City, Sichuan, China
Graduated: 1986
Languages:
English
Description:
Dr. Huang graduated from the The Third Military Med Univ, Chongqing City, Sichuan, China in 1986. She works in Madison, WI and specializes in Anatomic Pathology & Clinical Pathology. Dr. Huang is affiliated with University Of Wisconsin Hospital.
Wei Huang Photo 4

Wei Huang

View page
Specialties:
Ophthalmology
Work:
Charlotte Eye Ear Nose & Throat Associates
10305 Hamptons Park Dr STE 201, Huntersville, NC 28078
(704) 295-3600 (phone), (704) 892-3181 (fax)

Charlotte Eye Ear Nose & Throat Associates
646 Hartness Rd, Statesville, NC 28677
(704) 872-4108 (phone), (704) 873-6517 (fax)
Education:
Medical School
The Fourth Military Med Univ, Xian City, Shaanxi, China
Graduated: 1996
Languages:
English
Spanish
Description:
Dr. Huang graduated from the The Fourth Military Med Univ, Xian City, Shaanxi, China in 1996. She works in Huntersville, NC and 1 other location and specializes in Ophthalmology. Dr. Huang is affiliated with Carolinas Medical Center, Iredell Memorial Hospital and Novant Health Huntersville Medical Center.
Wei Huang Photo 5

Wei Huang

View page
Specialties:
Physical Medicine & Rehabilitation
Anatomic Pathology
Clinical Pathology/Laboratory Medicine
Education:
Third Military Medical University (1986)
Wei Huang Photo 6

Wei S Huang, Alameda CA

View page
Specialties:
Dentist
Address:
2245 Santa Clara Ave, Alameda, CA 94501

Resumes

Resumes

Wei Huang Photo 7

Wei Huang St. Louis, MO

View page
Work:
Dierbergs Family Market

Aug 2010 to 2000
Bakery Associate
Education:
University of Missouri-St. Louis
St. Louis, MO
2012 to 2014
Bachelor of Science Business Administration in International Business
St. Louis Community College
2010 to 2012
Associate of Art in Business Administration
Skills:
Exposure to: Microsoft Word, Excel, and Outlook. Three years experiences in the field of customer service. Proficient in Chinese and Taiwanese language. Strong grasp of planning and direction of projects and organizational skills. Time management and multi-tasking ability. Strong analytical skills.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Wei Sheng Huang
President
WEI SHENG HUANG DDS., INC
2245 Santa Clara Ave STE #2, Alameda, CA 94501
Wei X. Huang
President
CHINA FIRST INC
1077 Powell St, San Francisco, CA 94108
Wei Huang
Principal
Zone Hair Design
Beauty Shop
2004 Irving St, San Francisco, CA 94122
(415) 753-2283
Wei Sheng Huang
Principal
The Dental Practice of Wei Huang DDS Inc
Dentist's Office
2245 Santa Clara Ave, Alameda, CA 94501
Wei Huang
Jd Brothers LLC
Investment · Property Management · Real Estate Investments
530 Showers Dr, Mountain View, CA 94040
544 San Antonio Rd, Mountain View, CA 94040
Wei Chun Huang
Zen Toolworks, LLC
Wooden Tool · Business Services at Non-Commercial Site
1426 Candelero Dr, Walnut Creek, CA 94598
Wei Huang
Concessions Management-LS at Lax Tbit, LLC
Wei Huang
LS-Concessions Management at Lax Tbit, LLC

Publications

Wikipedia

Huang Wei

View page

Huang Wei (19041989) was a Chinese Nationalist military general who fought in the Encirclement Campaigns, Second Sino-Japanese War and Chinese Civil War. Huang was ...

Us Patents

Methods Of Evaluating Viral Entry Inhibitors Using Patient Derived Envelope Protein Constructs

View page
US Patent:
7097970, Aug 29, 2006
Filed:
Jun 4, 2001
Appl. No.:
09/874475
Inventors:
Christos J. Petropoulos - Half Moon Bay CA, US
Neil T. Parkin - Belmont CA, US
Jeanette M. Whitcomb - San Mateo CA, US
Wei Huang - Foster City CA, US
Assignee:
Monogram Biosciences, Inc. - South San Francisco CA
International Classification:
C12Q 1/70
US Classification:
435 5, 435 6, 435 71, 435 721, 435 691, 4353201, 514 44, 530 2372
Abstract:
The invention provides a method for identifying whether a compound inhibits entry of a virus into a cell which comprises: (a) obtaining nucleic acid encoding a viral envelope protein from a patient infected by the virus; (b) co-transfecting into a first cell (i) the nucleic acid of step (a), and (ii) a viral expression vector which lacks a nucleic acid encoding an envelope protein, and which comprises an indicator nucleic acid which produces a detectable signal, such that the first cell produces viral particles comprising the envelope protein encoded by the nucleic acid obtained from the patient; (c) contacting the viral particles produced in step (b) with a second cell in the presence of the compound, wherein the second cell expresses a cell surface receptor to which the virus binds; (d) measuring the amount of signal produced by the second cell in order to determine the infectivity of the viral particles; and (e) comparing the amount of signal measured in step (d) with the amount of signal produced in the absence of the compound, wherein a reduced amount of signal measured in the presence of the compound indicates that the compound inhibits entry of the virus into the second cell.

Methods Of Evaluating Viral Entry Inhibitors Using Patient Derived Envelope Protein Constructs

View page
US Patent:
7169551, Jan 30, 2007
Filed:
Dec 29, 2005
Appl. No.:
11/323189
Inventors:
Christos J. Petropoulos - Half Moon Bay CA, US
Neil T. Parkin - Belmont CA, US
Jeanette Whitcomb - San Mateo CA, US
Wei Huang - Foster City CA, US
Assignee:
Monogram Biosciences, Inc. - South San Franisco CA
International Classification:
C12Q 1/70
US Classification:
435 5, 435 6, 435 71, 435 721, 4353201, 536 2372
Abstract:
The invention provides a method for identifying whether a compound inhibits entry of a virus into a cell which comprises: (a) obtaining nucleic acid encoding a viral envelope protein from a patient infected by the virus; (b) co-transfecting into a first cell (i) the nucleic acid of step (a), and (ii) a viral expression vector which lacks a nucleic acid encoding an envelope protein, and which comprises an indicator nucleic acid which produces a detectable signal, such that the first cell produces viral particles comprising the envelope protein encoded by the nucleic acid obtained from the patient; (c) contacting the viral particles produced in step (b) with a second cell in the presence of the compound, wherein the second cell expresses a cell surface receptor to which the virus binds; (d) measuring the amount of signal produced by the second cell in order to determine the infectivity of the viral particles; and (e) comparing the amount of signal measured in step (d) with the amount of signal produced in the absence of the compound, wherein a reduced amount of signal measured in the presence of the compound indicates that the compound inhibits entry of the virus into the second cell.

Methods Of Evaluating Cell Surface Receptor Binding Of A Patient Derived Population Of Viral Envelope Protein Constructs

View page
US Patent:
7235356, Jun 26, 2007
Filed:
Sep 21, 2005
Appl. No.:
11/233461
Inventors:
Christos J. Petropoulos - Half Moon Bay CA, US
Neil T. Parkin - Belmont CA, US
Jeanette Whitcomb - San Mateo CA, US
Wei Huang - Foster City CA, US
Assignee:
Monogram Biosciences, Inc. - South San Franisco CA
International Classification:
C12Q 1/70
US Classification:
435 5, 435 6, 435 71, 435 721, 4353201, 536 2372
Abstract:
The invention provides a method for identifying whether a compound inhibits entry of a virus into a cell which comprises: (a) obtaining nucleic acid encoding a viral envelope protein from a patient infected by the virus; (b) co-transfecting into a first cell (i) the nucleic acid of step (a), and (ii) a viral expression vector which lacks a nucleic acid encoding an envelope protein, and which comprises an indicator nucleic acid which produces a detectable signal, such that the first cell produces viral particles comprising the envelope protein encoded by the nucleic acid obtained from the patient; (c) contacting the viral particles produced in step (b) with a second cell in the presence of the compound, wherein the second cell expresses a cell surface receptor to which the virus binds; (d) measuring the amount of signal produced by the second cell in order to determine the infectivity of the viral particles; and (e) comparing the amount of signal measured in step (d) with the amount of signal produced in the absence of the compound, wherein a reduced amount of signal measured in the presence of the compound indicates that the compound inhibits entry of the virus into the second cell.

Logical-To-Physical Lane Assignment To Reduce Clock Power Dissipation In A Bus Having A Variable Link Width

View page
US Patent:
7370132, May 6, 2008
Filed:
Nov 16, 2005
Appl. No.:
11/281718
Inventors:
Wei Je Huang - Fremont CA, US
Luc R. Bisson - San Jose CA, US
Oren Rubinstein - Sunnyvale CA, US
Michael B. Diamond - Los Gatos CA, US
William B. Simms - San Jose CA, US
Assignee:
Nvidia Corporation - Santa Clara CA
International Classification:
G06F 13/40
US Classification:
710307, 710305, 710310
Abstract:
A bus permits the number of active serial data lanes of a data link to be re-negotiated in response to changes in bus bandwidth requirements. In one embodiment, clock buffers not required to drive active data lanes are placed in an inactive state to reduce clock power dissipation.

Method For Determining Human Immunodeficiency Virus (Hiv) Coreceptor Utilization By Examining Gp41 Molecular Determinants

View page
US Patent:
8114585, Feb 14, 2012
Filed:
Jun 12, 2007
Appl. No.:
12/304418
Inventors:
Wei Huang - Foster City CA, US
Assignee:
Monogram Biosciences, Inc. - South San Francisco CA
International Classification:
C12Q 1/70
C12Q 1/68
A61K 39/21
US Classification:
435 5, 435 61, 4242081
Abstract:
The invention provides a method for determining whether a human immunodeficiency virus is likely to be have enhanced ability to enter a cell expressing CD4 and CXCR4 relative to a reference HIV. In certain aspects, the methods comprise detecting one or more amino acid in an envelope protein of the HIV associated with enhanced ability to enter CD4- and CXCR4-expressing cells and determining that the HIVs ability to enter such cells is enhanced relative to a reference HIV, e. g. , an HIV that does not comprise such amino acid(s).

Compositions And Methods For Determining The Replication Capacity Of A Pathogenic Virus

View page
US Patent:
20040063191, Apr 1, 2004
Filed:
Jul 1, 2003
Appl. No.:
10/612604
Inventors:
Wei Huang - Foster City CA, US
Mary Wrin - Fremont CA, US
Jeff Beauchaine - Daly City CA, US
Jeannette Whitcomb - San Mateo CA, US
Christos Petropoulos - Half Moon Bay CA, US
Neil Parkin - Belmont CA, US
International Classification:
C12N001/20
US Classification:
435/252300
Abstract:
This invention relates to compositions and methods for determining the replication capacity of a non-nucleoside reverse transcriptase inhibitor resistant virus. The compositions and methods are useful for identifying effective drug regimens for the treatment of viral infections, and identifying and determining the biological effectiveness of potential therapeutic compounds.

Compositions And Methods For Evaluating Viral Receptor/Co-Receptor Usage And Inhibitors Of Virus Entry Using Recombinant Virus Assays

View page
US Patent:
20040110125, Jun 10, 2004
Filed:
Jun 4, 2002
Appl. No.:
10/164290
Inventors:
Christos Petropoulos - Half Moon Bay CA, US
Neil Parkin - Belmont CA, US
Jeannette Whitcomb - San Mateo CA, US
Wei Huang - Foster City CA, US
International Classification:
C12Q001/70
C12Q001/68
US Classification:
435/005000, 435/006000
Abstract:
The invention provides a method for identifying whether a compound inhibits entry of a virus into a cell which comprises: (a) obtaining nucleic acid encoding a viral envelope protein from a patient infected by the virus; (b) co-transfecting into a first cell (i) the nucleic acid of step (a), and (ii) a viral expression vector which lacks a nucleic acid encoding an envelope protein, and which comprises an indicator nucleic acid which produces a detectable signal, such that the first cell produces viral particles comprising the envelope protein encoded by the nucleic acid obtained from the patient; (c) contacting the viral particles produced in step (b) with a second cell in the presence of the compound, wherein the second cell expresses a cell surface receptor to which the virus binds; (d) measuring the amount of signal produced by the second cell in order to determine the infectivity of the viral particles; and (e) comparing the amount of signal measured in step (d) with the amount of signal produced in the absence of the compound, wherein a reduced amount of signal measured in the presence of the compound indicates that the compound inhibits entry of the virus into the second cell.

Storing Log Data Efficiently While Supporting Querying To Assist In Computer Network Security

View page
US Patent:
20080162592, Jul 3, 2008
Filed:
Dec 28, 2007
Appl. No.:
11/966078
Inventors:
Wei Huang - Fremont CA, US
Wenting Tang - Sunnyvale CA, US
Christian F. Beedgen - Cupertino CA, US
Assignee:
ARCSIGHT, INC. - Cupertino CA
International Classification:
G06F 17/30
US Classification:
707202, 707E17007
Abstract:
A logging system includes an event receiver and a storage manager. The receiver receives log data, processes it, and outputs a data “chunk.” The manager receives data chunks and stores them so that they can be queried. The receiver includes buffers that store events and a metadata structure that stores metadata about the contents of the buffers. The metadata includes a unique identifier associated with the receiver, the number of events in the buffers, and, for each “field of interest,” a minimum value and a maximum value that reflect the range of values of that field over all of the events in the buffers. A chunk includes the metadata structure and a compressed version of the contents of the buffers. The metadata structure acts as a search index when querying event data. The logging system can be used in conjunction with a security information/event management (SIEM) system.
Control profile
Wei Duo Huang from San Francisco, CA, age ~61 Get Report